| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0215(19980831)77:5<684::AID-IJC4>3.0.CO;2-R |
| P698 | PubMed publication ID | 9688299 |
| P2093 | author name string | X Shao | |
| T Sato | |||
| H Yano | |||
| H Kanki | |||
| R Parsons | |||
| R Tandon | |||
| L G Close | |||
| G Samara | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | head and neck squamous cell carcinoma | Q18348812 |
| mutational analysis | Q1955810 | ||
| P304 | page(s) | 684-688 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma | |
| P478 | volume | 77 |
| Q34106064 | A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma |
| Q33511579 | Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models |
| Q36622783 | Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma |
| Q59611470 | Biomarker driven treatment of head and neck squamous cell cancer |
| Q92445608 | Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma |
| Q57791102 | Comparative Genomic Hybridization Analysis Detects Frequent Over-Representation of DNA Sequences at 3q, 7p, and 8q in Head and Neck Carcinomas |
| Q36622406 | Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus |
| Q43860454 | Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10. |
| Q39097109 | Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma |
| Q36174374 | Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation |
| Q27852227 | Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers |
| Q28593244 | Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression |
| Q51661724 | Genetic profile of PTEN gene in Indian oral squamous cell carcinoma primary tumors. |
| Q59465394 | Genomically personalized therapy in head and neck cancer |
| Q52827239 | Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. |
| Q28834533 | Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma |
| Q37480360 | Immunohistochemical expression of phosphatase and tensin homolog in histologic gradings of oral squamous cell carcinoma |
| Q42545098 | Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors |
| Q35722714 | Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. |
| Q91296617 | Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma |
| Q77995588 | Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis |
| Q38188373 | Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression. |
| Q28082815 | Molecular Aspects of Head and Neck Cancer Therapy |
| Q33894100 | Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma |
| Q33774967 | Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity |
| Q30662103 | New approaches to the understanding of the molecular basis of oral cancer |
| Q35224923 | Oral cancer: risk factors and molecular pathogenesis |
| Q37520558 | PI3K-PTEN dysregulation leads to mTOR-driven upregulation of the core clock gene BMAL1 in normal and malignant epithelial cells. |
| Q92894128 | PTEN Is Associated With Worse Local Control in Early Stage Supraglottic Laryngeal Cancer Treated With Radiotherapy |
| Q47877197 | PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma |
| Q36801074 | PTEN deficiency contributes to the development and progression of head and neck cancer. |
| Q36506366 | PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma |
| Q92704156 | PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma |
| Q38407414 | PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients. |
| Q73739349 | PTEN/MMAC1 in malignant melanoma and its importance for tumor progression |
| Q34502557 | RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC). |
| Q35563110 | Targeting tumor cells by enhancing radiation sensitivity |
| Q30365726 | The determinants of head and neck cancer: Unmasking the PI3K pathway mutations |
| Q36659339 | The molecular pathogenesis of head and neck squamous cell carcinoma |
| Q38203467 | The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact |
| Q37270446 | The role of PTEN signaling perturbations in cancer and in targeted therapy |
| Q64889726 | mTOR Signalling in Head and Neck Cancer: Heads Up. |
Search more.